Cargando…

Multifunctional Platinum@BSA–Rapamycin Nanocarriers for the Combinatorial Therapy of Cerebral Cavernous Malformation

[Image: see text] Platinum nanoparticles (PtNPs) are antioxidant enzyme-mimetic nanomaterials with significant potential for the treatment of complex diseases related to oxidative stress. Among such diseases, Cerebral Cavernous Malformation (CCM) is a major cerebrovascular disorder of genetic origin...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Luca, Elisa, Pedone, Deborah, Moglianetti, Mauro, Pulcini, Daniele, Perrelli, Andrea, Retta, Saverio Francesco, Pompa, Pier Paolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2018
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288776/ https://www.ncbi.nlm.nih.gov/pubmed/30556006 http://dx.doi.org/10.1021/acsomega.8b01653

Ejemplares similares

Multidrug-Loaded Lipid Nanoemulsions for the Combinatorial Treatment of Cerebral Cavernous Malformation Disease
por: Perrelli, Andrea, et al.
Publicado: (2023)

Dicarbonyl Stress and S-Glutathionylation in Cerebrovascular Diseases: A Focus on Cerebral Cavernous Malformations
por: Antognelli, Cinzia, et al.
Publicado: (2020)

Next-Generation Sequencing Advances the Genetic Diagnosis of Cerebral Cavernous Malformation (CCM)
por: Benedetti, Valerio, et al.
Publicado: (2022)

Platinum Nanoparticles Decrease Reactive Oxygen Species and Modulate Gene Expression without Alteration of Immune Responses in THP-1 Monocytes
por: Gatto, Francesca, et al.
Publicado: (2018)

Hydrogen Promotes the Growth of Platinum Pyramidal Nanocrystals by Size-Dependent Symmetry Breaking
por: Nelli, Diana, et al.
Publicado: (2023)

KRIT1 Loss-Of-Function Associated with Cerebral Cavernous Malformation Disease Leads to Enhanced S-Glutathionylation of Distinct Structural and Regulatory Proteins
por: Cianfruglia, Laura, et al.
Publicado: (2019)

Oxidative stress and inflammation in cerebral cavernous malformation disease pathogenesis: Two sides of the same coin
por: Retta, Saverio Francesco, et al.
Publicado: (2016)

Intracellular Antioxidant Activity of Biocompatible Citrate-Capped Palladium Nanozymes
por: Moglianetti, Mauro, et al.
Publicado: (2020)

Distant Recurrence of a Cerebral Cavernous Malformation in the Vicinity of a Developmental Venous Anomaly: Case Report of Local Oxy-Inflammatory Events
por: Bianconi, Andrea, et al.
Publicado: (2022)

Identification of galectin-3 as a novel potential prognostic/predictive biomarker and therapeutic target for cerebral cavernous malformation disease
por: Kar, Souvik, et al.
Publicado: (2023)

PMA-Induced THP-1 Macrophage Differentiation is Not Impaired by Citrate-Coated Platinum Nanoparticles
por: Gatto, Francesca, et al.
Publicado: (2017)

Ultrasmall, Coating-Free, Pyramidal Platinum Nanoparticles for High Stability Fuel Cell Oxygen Reduction
por: Mastronardi, Valentina, et al.
Publicado: (2022)

Nanozymes based on octahedral platinum nanocrystals with {111} surface facets: glucose oxidase mimicking activity in electrochemical sensors
por: Mazzotta, Elisabetta, et al.
Publicado: (2023)

Defective autophagy is a key feature of cerebral cavernous malformations
por: Marchi, Saverio, et al.
Publicado: (2015)

KRIT1 loss-of-function induces a chronic Nrf2-mediated adaptive homeostasis that sensitizes cells to oxidative stress: Implication for Cerebral Cavernous Malformation disease
por: Antognelli, Cinzia, et al.
Publicado: (2018)

Beyond multiple mechanisms and a unique drug: Defective autophagy as pivotal player in cerebral cavernous malformation pathogenesis and implications for targeted therapies
por: Marchi, Saverio, et al.
Publicado: (2016)

A multi-line platinum nanozyme-based lateral flow device for the colorimetric evaluation of total antioxidant capacity in different matrices
por: Scarsi, Anna, et al.
Publicado: (2023)

Tumor microenvironment-responsive BSA nanocarriers for combined chemo/chemodynamic cancer therapy
por: Zhang, Ruiyi, et al.
Publicado: (2022)

Cytochrome P450 and matrix metalloproteinase genetic modifiers of disease severity in Cerebral Cavernous Malformation type 1
por: Choquet, Hélène, et al.
Publicado: (2016)

From a Chemotherapeutic Drug to a High-Performance Nanocatalyst: A Fast Colorimetric Test for Cisplatin Detection at ppb Level
por: Mastronardi, Valentina, et al.
Publicado: (2022)

Giant cavernous malformations
por: Linsler, Stefan
Publicado: (2016)

Resection of Cavernous Malformations
por: Morcos, Jacques J., et al.
Publicado: (2019)

A Spinal Cavernous Malformation in Multiple Cerebral Cavernous Venous Malformations Syndrome
por: Vangrinsven, Guillaume, et al.
Publicado: (2023)

Multifunctional Nanocarriers for Lung Drug Delivery
por: Pontes, Jorge F., et al.
Publicado: (2020)

Progressive tentorial cavernous malformation
por: Furuta, Takuya, et al.
Publicado: (2012)

The cerebral cavernous malformations proteins
por: Li, Xiaofeng, et al.
Publicado: (2015)

Amide Proton Transfer Imaging of Cavernous Malformation in the Cavernous Sinus
por: Bohara, Manisha, et al.
Publicado: (2018)

Nanocarriers containing platinum compounds for combination chemotherapy
por: Fang, Guihua, et al.
Publicado: (2022)

Varying clinical presentations of familial cerebral cavernous malformations (CCMs) and spinal cord cavernous malformations (SCCMs)
por: Nicholas-Bublick, Selena, et al.
Publicado: (2015)

Transnasal Endoscopic Approach for Resection of a Cavernous Sinus Cavernous Malformation
por: Zhao, Lei, et al.
Publicado: (2023)

Advances in the biology of cerebral cavernous malformations
por: Kivelev, Juri, et al.
Publicado: (2010)

Advances in the biology of cerebral cavernous malformations
por: Hauptman, Jason S., et al.
Publicado: (2010)

Unusual Presentation of Cerebral Cavernous Malformation
por: Kim, Won-Hyung, et al.
Publicado: (2015)

Postzygotic mosaicism in cerebral cavernous malformation
por: Rath, Matthias, et al.
Publicado: (2020)

Vitamin D Deficiency and the Risk of Cerebrovascular Disease
por: Kim, Hyun Ah, et al.
Publicado: (2020)

Synthesis of Citrate-Coated Penta-twinned Palladium Nanorods and Ultrathin Nanowires with a Tunable Aspect Ratio
por: Mastronardi, Valentina, et al.
Publicado: (2020)

Multifunctional and stimuli-responsive nanocarriers for targeted therapeutic delivery
por: Majumder, Joydeb, et al.
Publicado: (2020)

Biological Activities, Health Benefits, and Therapeutic Properties of Avenanthramides: From Skin Protection to Prevention and Treatment of Cerebrovascular Diseases
por: Perrelli, Andrea, et al.
Publicado: (2018)

Pineal Cavernous Malformations: Report of Two Cases
por: Kim, Dong-Seok, et al.
Publicado: (2005)

Cavernous malformation of the optic chiasm: An uncommon location
por: Alafaci, Concetta, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_qrhm4ljj0vbsulv3n438p4eh4u